Home Healthcare Medical Devices Serum Free Light Chain Assays Market

Serum Free Light Chain Assays Market Size, Share & Trends Analysis Report By Technique (Latex Turbidimetric, Latex Nephelometric, ELISA, Lateral Flow Immunoassay), By Indication (Multiple Myeloma, Light Chain Amyloidosis, Others), By End User (Hospital Laboratories, Clinical & Pathology Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Serum Free Light Chain Assays Market, By Technique 2022-2034 (USD MILLION/ Units)
    1. Latex Turbidimetric
    2. Latex Nephelometric
    3. ELISA
    4. Lateral Flow Immunoassay
  2. Serum Free Light Chain Assays Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Multiple Myeloma
    2. Light Chain Amyloidosis
    3. Others
  3. Serum Free Light Chain Assays Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospital Laboratories
    2. Clinical & Pathology Laboratories
    3. Others
  4. Regional Serum Free Light Chain Assays Market
    1. North America
      1. North America Serum Free Light Chain Assays Market By Technique 2022-2034 (USD MILLION/ Units)
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
      2. North America Serum Free Light Chain Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Myeloma
        2. Light Chain Amyloidosis
        3. Others
      3. North America Serum Free Light Chain Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital Laboratories
        2. Clinical & Pathology Laboratories
        3. Others
      4. U.S.
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      5. Canada
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
    2. Europe
      1. Europe Serum Free Light Chain Assays Market By Technique 2022-2034 (USD MILLION/ Units)
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
      2. Europe Serum Free Light Chain Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Myeloma
        2. Light Chain Amyloidosis
        3. Others
      3. Europe Serum Free Light Chain Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital Laboratories
        2. Clinical & Pathology Laboratories
        3. Others
      4. U.K.
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      5. Germany
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      6. France
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      7. Spain
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      8. Italy
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      9. Russia
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      10. Nordic
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      11. Benelux
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      12. Rest of Europe
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
    3. APAC
      1. APAC Serum Free Light Chain Assays Market By Technique 2022-2034 (USD MILLION/ Units)
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
      2. APAC Serum Free Light Chain Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Myeloma
        2. Light Chain Amyloidosis
        3. Others
      3. APAC Serum Free Light Chain Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital Laboratories
        2. Clinical & Pathology Laboratories
        3. Others
      4. China
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      5. Korea
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      6. Japan
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      7. India
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      8. Australia
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      9. Taiwan
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      10. South East Asia
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      11. Rest of Asia-Pacific
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Serum Free Light Chain Assays Market By Technique 2022-2034 (USD MILLION/ Units)
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
      2. Middle East and Africa Serum Free Light Chain Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Myeloma
        2. Light Chain Amyloidosis
        3. Others
      3. Middle East and Africa Serum Free Light Chain Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital Laboratories
        2. Clinical & Pathology Laboratories
        3. Others
      4. UAE
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      5. Turkey
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      6. Saudi Arabia
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      7. South Africa
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      8. Egypt
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      9. Nigeria
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      10. Rest of MEA
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
    5. LATAM
      1. LATAM Serum Free Light Chain Assays Market By Technique 2022-2034 (USD MILLION/ Units)
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
      2. LATAM Serum Free Light Chain Assays Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Myeloma
        2. Light Chain Amyloidosis
        3. Others
      3. LATAM Serum Free Light Chain Assays Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospital Laboratories
        2. Clinical & Pathology Laboratories
        3. Others
      4. Brazil
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      5. Mexico
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      6. Argentina
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      7. Chile
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      8. Colombia
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
      9. Rest of LATAM
        1. Latex Turbidimetric
        2. Latex Nephelometric
        3. ELISA
        4. Lateral Flow Immunoassay
        5. Multiple Myeloma
        6. Light Chain Amyloidosis
        7. Others
        8. Hospital Laboratories
        9. Clinical & Pathology Laboratories
        10. Others
Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.